1 |
Cell adhesion_Chemokines and adhesion |
100 |
52 |
9.44E − 15 |
8.17E − 12 |
2 |
Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling
|
111 |
54 |
1.07E − 13 |
4.64E − 11 |
3 |
Cytoskeleton remodeling_Cytoskeleton remodeling |
102 |
49 |
2.72E − 12 |
7.83E − 10 |
4 |
Ligand-independent activation of androgen receptor in prostate cancer |
67 |
35 |
1.93E − 10 |
4.18E − 08 |
5 |
Development_EGFR signaling pathway |
71 |
36 |
3.19E − 10 |
5.52E − 08 |
6 |
Signal transduction_PKA signaling |
51 |
29 |
4.89E − 10 |
6.59E − 08 |
7 |
Immune response_HSP60 and HSP70/TLR signaling pathway |
54 |
30 |
5.33E − 10 |
6.59E − 08 |
8 |
Signal transduction_PTEN pathway |
46 |
27 |
7.32E − 10 |
7.92E − 08 |
9 |
Aberrant B-Raf signaling in melanoma progression |
55 |
30 |
9.73E − 10 |
9.35E − 08 |
10 |
Immune response_HMGB1/RAGE signaling pathway |
53 |
29 |
1.68E − 09 |
1.45E − 07 |
11 |
Apoptosis and survival_BAD phosphorylation |
42 |
25 |
2.09E − 09 |
1.64E − 07 |
12 |
DNA damage_ATM/ATR regulation of G1/S checkpoint |
32 |
21 |
3.3E − 09 |
2.33E − 07 |
13 |
Signal transduction_AKT signaling |
43 |
25 |
4.14E − 09 |
2.33E − 07 |
14 |
Apoptosis and survival_TNFR1 signaling pathway |
43 |
25 |
4.14E − 09 |
2.33E − 07 |
15 |
Immune response_MIF-induced cell adhesion, migration and angiogenesis |
46 |
26 |
4.65E − 09 |
2.33E − 07 |
16 |
Development_TGF-β-dependent induction of EMT via RhoA, PI3K, and ILK |
46 |
26 |
4.65E − 09 |
2.33E − 07 |
17 |
Ovarian cancer (main signaling cascades) |
64 |
32 |
4.84E − 09 |
2.33E − 07 |
18 |
Development_Regulation of epithelial-to-mesenchymal transition (EMT) |
64 |
32 |
4.84E − 09 |
2.33E − 07 |
19 |
LRRK2 in neurons in Parkinson disease |
33 |
21 |
7.54E − 09 |
3.43E − 07 |
20 |
Development_Gastrin in cell growth and proliferation |
62 |
31 |
8.42E − 09 |
3.53E − 07 |
21 |
Development_PIP3 signaling in cardiac myocytes |
47 |
26 |
8.63E − 09 |
3.53E − 07 |
22 |
Cell cycle_Chromosome condensation in prometaphase |
21 |
16 |
8.97E − 09 |
3.53E − 07 |
23 |
IGF family signaling in colorectal cancer |
60 |
30 |
1.46E − 08 |
5.51E − 07 |
24 |
Development_Cytokine-mediated regulation of megakaryopoiesis |
57 |
29 |
1.54E − 08 |
5.54E − 07 |
25 |
Development_Prolactin receptor signaling |
58 |
29 |
2.55E − 08 |
8.53E − 07 |